MENU
+Compare
BGMS
Stock ticker: NASDAQ
AS OF
Mar 6 closing price
Price
$0.95
Change
-$0.04 (-4.04%)
Capitalization
5M

BGMS Bio Green Med Solution Inc Forecast, Technical & Fundamental Analysis

Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases... Show more

Industry: #Biotechnology
BGMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BGMS with price predictions
Mar 06, 2026

BGMS's RSI Indicator ascending out of oversold territory

The RSI Oscillator for BGMS moved out of oversold territory on February 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 46 similar instances when the indicator left oversold territory. In of the 46 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for BGMS just turned positive on February 18, 2026. Looking at past instances where BGMS's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BGMS advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

BGMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BGMS as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BGMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BGMS entered a downward trend on February 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.685) is normal, around the industry mean (29.763). P/E Ratio (0.000) is within average values for comparable stocks, (45.589). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.808). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (12.690) is also within normal values, averaging (314.344).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BGMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BGMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of mechanism-targeted drugs to treat human cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HIT1.860.18
+10.71%
Health In Tech Inc
FCUV4.360.01
+0.23%
Focus Universal Inc.
BALL62.53-0.69
-1.09%
Ball Corp
PANL8.35-0.33
-3.86%
Pangaea Logistics Solutions Ltd
HE14.92-0.63
-4.05%
Hawaiian Electric Industries

BGMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BGMS has been loosely correlated with KAPA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BGMS jumps, then KAPA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGMS
1D Price
Change %
BGMS100%
-1.05%
KAPA - BGMS
38%
Loosely correlated
-3.98%
MIRM - BGMS
36%
Loosely correlated
-1.84%
BRNS - BGMS
31%
Poorly correlated
+1.62%
ORMP - BGMS
30%
Poorly correlated
-3.81%
IMMP - BGMS
27%
Poorly correlated
N/A
More